DnB Asset Management’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $214K | Buy |
9,253
+1,488
| +19% | +$34.4K | ﹤0.01% | 694 |
|
2025
Q1 | $210K | Buy |
7,765
+1,987
| +34% | +$53.6K | ﹤0.01% | 705 |
|
2024
Q4 | $309K | Sell |
5,778
-475
| -8% | -$25.4K | ﹤0.01% | 685 |
|
2024
Q3 | $284K | Buy |
6,253
+980
| +19% | +$44.5K | ﹤0.01% | 681 |
|
2024
Q2 | $221K | Buy |
+5,273
| New | +$221K | ﹤0.01% | 692 |
|